A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects with Attention-Deficit Hyperactivity Disorder (CEES ADHD)
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Ironshore Pharmaceuticals & Development, Inc
Start Date
June 15, 2014
End Date
April 20, 2015
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Ironshore Pharmaceuticals & Development, Inc
Start Date
June 15, 2014
End Date
April 20, 2015